Filter

461 - 470 of 531 Results

  • Medicare+Choice Withdrawals: Understanding Key Factors

    Report

    To help understand why M+C plans have exited or limited their participation in the M+C program in recent years, this report presents an empirical analysis of the factors associated with plan withdrawals between 1999 and 2001. This analysis explores factors such as M+C payment levels, local market characteristics, and individual health plan characteristics to help predict plan withdrawals and draw inferences about the types of plans and markets that have been most adversely affected. Report

  • Medicare and Prescription Drugs: A Chartpack

    Report

    This chartpack presents a brief overview of the state of prescription drug coverage among the Medicare population. It reviews the impact of lack of coverage on beneficiaries' access to prescription drugs, as well as current levels of total and out-of-pocket spending on prescription drugs. Chart Pack

  • Survey on Health Care

    Other Post

    NPR/Kaiser Family Foundation/Harvard Kennedy School of Government Survey on Health Care A survey by NPR, the Kaiser Family Foundation, and Harvard s Kennedy School of Government finds that many Americans have real problems when it comes to accessing and paying for health care, and even if they haven't yet faced a problem, many worry about getting and paying for care in the future. The survey also shows that, while people think helping seniors with the…

  • Medicare Prescription Drug Coverage: Facts, Options, and Implications

    Event Date:
    Event

    Testimony by Patricia Neuman, Sc.D., vice president and director of the Foundation's Medicare Policy Project, for the House Committee on Energy and Commerce, Subcommittee on Health, hearing on Creating a Medicare Prescription Drug Benefit: begins with a brief review of existing sources of prescription drug coverage for the Medicare population and a discussion of how the lack of coverage affects people on Medicare. It then reviews broad approaches to improving prescription drug coverage, considers the…

  • 2001 Retiree Health and Prescription Drug Coverage Survey-6020

    Report

    2001 Retiree Health and Prescription Drug Coverage Survey This survey, released by the Kaiser Family Foundation, The Commonwealth Fund, and HRET, profiles retiree health coverage for Medicare-age (65+) retirees, including the amount retirees pay for coverage compared to active workers, cost-sharing for prescription drugs, and eligibility requirements for retiree benefits. The survey is based on the annual KFF/HRET Employer Health Benefits Survey News Release: New Survey Shows Retiree Health Benefits Continue to Decline Chart Pack

  • Solvency or Affordability?  Ways to Measure Medicare’s Financial Health

    Report

    Solvency or Affordability? Ways to Measure Medicare's Financial Health This report examines different ways of measuring Medicare s financial health and considers their implications for the future of the program and the people it serves. Using an alternative measure of Medicare's long-term affordability that focuses on workers' capacity to absorb additional costs over time, the analysis concludes that the nation could afford to pay more for Medicare in the future without imposing an undue burden…

  • Issues Facing Medicaid and CHIP

    Event Date:
    Event

    Cindy Mann, senior fellow of the Commission, testified to the Senate Subcommittee on Public Health of the Health, Education, Labor and Pensions Committee on how to sustain and expand health care coverage for low-income children and families, and disabled and elderly people in these challenging times. TESTIMONY Download

  • State Variation in Medicaid Pharmacy Benefit Use Among Dual-Eligible Beneficiaries

    Report

    This study examines Medicaid pharmacy benefit use and spending among beneficiaries dually eligible for Medicare and Medicaid in 10 states by analyzing 1995 enrollment and claims data from a new 12-state database. The study finds that dual-eligibles are relatively high users of the Medicaid pharmacy benefit, with substantial variation in both drug use and spending among this population across the 10 study states. This variation appears to persist independent of beneficiaries' health status and is…